Skip to main content
SpringerLink
Log in

Anti-inflammatory treatment of chronic rhinosinusitis: A shifting paradigm

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Treatment of chronic rhinosinusitis still represents an unmet medical need. Presently, the US Food and Drug Administration has not approved any drugs for the treatment of this common condition. Various inflammatory processes are involved in the pathogenesis of chronic rhinosinusitis. Treatment of infection and surgical intervention to correct anatomic abnormalities often are inadequate in management when singly employed. Anti-inflammatory therapy such as topical corticosteroids and more recently long-term, low-dose macrolide therapy has been integrated into the treatment algorithm for chronic rhinosinusitis. Better classification and point-of-care identification of inflammatory features may improve choice of anti-inflammatory therapy and thus outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Benninger MS, Ferguson BJ, Hadley JA, et al.: Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129(3 Suppl):S1–S32.

    Article  PubMed  Google Scholar 

  2. Brook I: Bacteriology of chronic sinusitis and acute exacerbation of chronic sinusitis. Arch Otolaryngol Head Neck Surg 2006, 132:1099–1101.

    Article  PubMed  Google Scholar 

  3. Subramanian HN, Schectman KB, Hamilos DL, et al.: A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol 2002, 16:303–312.

    PubMed  Google Scholar 

  4. Legent F, Bordure P, Beauvillain C, et al.: A double-blind comparison of ciprofloxacin and amoxicillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994, 40(Suppl 1):8–15.

    PubMed  CAS  Google Scholar 

  5. Stammberger H: Endoscopic endonasal surgery-concepts in treatment of recurring rhinosinusitis. Part II. Surgical technique. Otolaryngol Head Neck Surg 1986, 94:147–156.

    PubMed  CAS  Google Scholar 

  6. Terris MH, Davidson TM: Review of published results for endoscopic sinus surgery. Ear Nose Throat J 1994, 73:574–580.

    PubMed  CAS  Google Scholar 

  7. Bhattacharyya N: Clinical outcomes after endoscopic sinus surgery. Curr Opin Allergy Clin Immunol 2006, 6:167–171.

    PubMed  Google Scholar 

  8. Lal D, Baroody FM, Weitzel EK, et al.: Total of IgE levels do not change one year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol 2006, 139:146–148.

    Article  PubMed  CAS  Google Scholar 

  9. Aukema AA, Mulder PG, Fokkens WJ: Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol 2005, 115:1017–1023.

    Article  PubMed  CAS  Google Scholar 

  10. Baraniuk JN, Maibach H: Pathophysiological classification of chronic rhinosinusitis. Respir Res 2005, 6:149.

    Article  PubMed  Google Scholar 

  11. Taghizadeh F, Hadley J, Osguthorpe J: Pharmacological treatments for rhinosinusitis. Expert Opin Pharmacother 2002, 3:305–313.

    Article  PubMed  CAS  Google Scholar 

  12. Van Cauwenberge P, Van Hoecke H, Bachert C: Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep 2006, 6:487–494.

    Article  PubMed  Google Scholar 

  13. Bachert C, Gevaert P, Holtappels G, et al.: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001, 107:607–614.

    Article  PubMed  CAS  Google Scholar 

  14. Demoly P, Crampette L, Mondain M, et al.: Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 1994, 94:95–108.

    Article  PubMed  CAS  Google Scholar 

  15. Nishimoto K, Kotaro U, Teruhiko H, et al.: Lymphocyte subsets in maxillary mucosa in chronic inflammation. Acta Otolaryngol (Stockh 1) 1982, 106:291–298.

    Article  Google Scholar 

  16. Suzuki H, Takahashi Y, Wataya H, et al.: Mechanism of neutrophil recruitment and induced by IL-8 in chronic sinusitis. J Allergy Clin Immunol 1996, 98:659–670.

    Article  PubMed  CAS  Google Scholar 

  17. Bachert C, Hauser U, Prem B, et al.: Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol Suppl 1995, 1:S44–S99.

    Article  Google Scholar 

  18. Border W, Ruoslahti E: Transforming growth factor B in disease: the dark side of tissue repair. J Clin Invest 1992, 90:1–7.

    Article  PubMed  CAS  Google Scholar 

  19. Coste A, Lefaucher J, Wang Q, et al.: Expression of the transforming growth factor B. isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg 1998, 124:1361–1366.

    PubMed  CAS  Google Scholar 

  20. Barnes PJ: Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin N Am 2005, 25:451–468.

    Article  Google Scholar 

  21. Mygind N, Pedersen CB, Prytz S, et al.: Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975, 5:159–164.

    Article  PubMed  CAS  Google Scholar 

  22. Deuschl H, Drettner B: Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977, 15:17–23.

    PubMed  CAS  Google Scholar 

  23. Holopainen E, Grahne B, Malmberg H, et al.: Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl 1982, 122:221–228.

    PubMed  CAS  Google Scholar 

  24. Tos M, Svendstrup F, Arndal H, et al.: Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps. Am J Rhinology 1998, 12:183–189.

    Article  CAS  Google Scholar 

  25. Vendelo JL, Illum P, Kristensen S, et al.: The effect of budesonide in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 1993, 18:524–527.

    Article  Google Scholar 

  26. Lildholdt T, Rundcrantz H, Lindquist N: Efficacy of topical corticosteroid powder for nasal polyps: a double-blind placebo-controlled study of budesonide. Clin Otolaryngol 1995, 20:26–30.

    Article  PubMed  CAS  Google Scholar 

  27. Holmberg K, Juliusson S, Balder B, et al.: Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 1997, 78:270–276.

    Article  PubMed  CAS  Google Scholar 

  28. Lund VJ, Flood J, Sykes AP, et al.: Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998, 124:513–518.

    PubMed  CAS  Google Scholar 

  29. Keith P, Nieminen J, Hollingworth K, et al.: Efficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000, 30:1460–1468.

    Article  PubMed  CAS  Google Scholar 

  30. Penttila M, Poulsen P, Hollingworth K, et al.: Dose-related efficacy and tolerability of fluticasone propionate nasal drops 400 micrograms once daily and twice-daily in the treatment of bilateral nasal polyposis: a placebo-controlled randomized study in adult patients. Clin Exp Allergy 2000, 30:94–102.

    Article  PubMed  CAS  Google Scholar 

  31. Cuenant G, Stipon JP, Plante-Longchamp G, et al.: Efficacy of nasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec 1986, 48:226–232.

    PubMed  CAS  Google Scholar 

  32. Sykes DA, Wilson R, Chan KL, et al.: Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet 1986, 2:359–360.

    Article  PubMed  CAS  Google Scholar 

  33. Parikh A, Scadding GK, Darby Y, et al.: Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001, 39:75–79.

    PubMed  CAS  Google Scholar 

  34. Lavigne F, Cameron L, Renzi PM, et al.: Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002, 112:858–864.

    Article  PubMed  CAS  Google Scholar 

  35. Lund VJ, Black JH, Szabo LZ, et al.: Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 2004, 42:57–62.

    PubMed  Google Scholar 

  36. Parnes SM: The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 2003, 11:184–191.

    Article  PubMed  Google Scholar 

  37. Parnes SM, Chuma AV: Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 2000, 79:18–20.

    PubMed  CAS  Google Scholar 

  38. Suzuki H, Asada Y, Ikeda K, et al.: Inhibitory effect of erythromycin on interleukin 8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. Laryngoscope 1999, 109:407–410.

    Article  PubMed  CAS  Google Scholar 

  39. Walwork B, Coman W, Mackay Sim A, et al.: Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor beta in chronic rhinosinusitis. Laryngoscope 2004, 114:286–290.

    Article  Google Scholar 

  40. Rubin BK, Druce H, Ramirez OE, et al.: Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Resp Crit Care Med 1997, 155:2018–2023.

    PubMed  CAS  Google Scholar 

  41. Cervin A, Walwork B: Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis. Otolaryngol Clin N Am 2005, 38:1339–1350.

    Article  Google Scholar 

  42. Hatipoglu U, Rubinstein I: Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm. Curr Allergy Asthma Rep 2005, 5:491–494.

    Article  PubMed  CAS  Google Scholar 

  43. Walwork B, Coman W, Mackay-Sim A, et al.: A double-blind randomized placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006, 116:189–193.

    Article  CAS  Google Scholar 

  44. Azuma A, Kudoh S: Diffuse panbronchiolitis in East Asia. Respirology 2006, 11:249–261.

    Article  PubMed  Google Scholar 

  45. Ponikau JU, Sherris DA, Kern EB, et al.: The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999, 74:877–884.

    Article  PubMed  CAS  Google Scholar 

  46. Weschta M, Rimek D, Formanek M, et al.: Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 2004, 113:1122–1128.

    Article  PubMed  CAS  Google Scholar 

  47. Weschta M, Rimek D, Formanek M, et al.: Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 2006, 132:743–747.

    Article  PubMed  Google Scholar 

  48. Ponikau JU, Sherris DA, Weaver A, et al.: Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005, 115:125–131.

    Article  PubMed  CAS  Google Scholar 

  49. Ebbens FA, Scadding GK, Badia L, et al.: Amphotericin B nasal lavages: Not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 2006, 118:1149–1156.

    Article  PubMed  CAS  Google Scholar 

  50. Heintz B, Schlenter WW, Kirsten R, et al.: Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis—a multicentric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol 1989, 27:530–534.

    PubMed  CAS  Google Scholar 

  51. van Agthoven M, Fokkens WJ, van de Merwe JP, et al.: Quality of life of patients with refractory chronic rhinosinusitis: effects of filgastrim treatment. Am J Rhinol 2001, 15:231–237.

    PubMed  Google Scholar 

  52. van Agthoven M, Uyl-de Groot CA, Fokkens WJ, et al.: Cost analysis of regular and filgastrim treatment in patients with refractory chronic rhinosinusitis. Rhinology 2002, 40:69–74.

    PubMed  Google Scholar 

  53. Jyonouchi H, Sun S, Kelly A, et al.: Effects of exogenous interferon gamma on patients with treatment resistant chronic rhinosinusitis and dysregulated interferon gamma production: a pilot study. Arch Otolaryngol Head Neck Surg 2003, 129:563–569.

    Article  PubMed  Google Scholar 

  54. Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992, 90:1045–1050.

    Article  PubMed  CAS  Google Scholar 

  55. Sancho R, Lucena C, Macho A, et al.: Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappa B activation and is a potent anti-inflammatory compound in vivo. Eur J Immunol 2002, 32:1753–1763.

    Article  PubMed  CAS  Google Scholar 

  56. Filiaci F, Zambetti G, Ciofalo A, et al.: Local treatment of aspecific nasal hyperreactivity with capsaicin. Allergol Immunopathol (Madr) 1994, 22:264–268.

    CAS  Google Scholar 

  57. Baudoin T, Kalogjera L, Hat J: Capsaicin significantly reduces sinonasal polyps. Acta Otolaryngol 2000, 120:307–311.

    Article  PubMed  CAS  Google Scholar 

  58. Passali D, Bernstein JM, Passali FM, et al.: Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 2003, 129:656–659.

    Article  PubMed  Google Scholar 

  59. Krouse HJ, Krouse JH: Complementary therapeutic practices in patients with chronic sinusitis. Clin Excell Nurse Pract 1999, 3:346–352.

    PubMed  CAS  Google Scholar 

  60. Guo R, Canter PH, Ernst E, et al.: Herbal medicines for the treatment of rhinosinusitis: A systematic review. Otolaryngol Head Neck Surg 2006, 135:496–506.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine (M/C 719), University of Chicago, CSB 920, Room 913-N, Chicago, IL, 60612-4325, USA

    Israel Rubinstein

Authors
  1. Umur Hatipoğlu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Israel Rubinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Israel Rubinstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatipoğlu, U., Rubinstein, I. Anti-inflammatory treatment of chronic rhinosinusitis: A shifting paradigm. Curr Allergy Asthma Rep 8, 154–161 (2008). https://doi.org/10.1007/s11882-008-0026-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-008-0026-6

Keywords

Search

Navigation